A Study Comparing the Efficacy of L19TNF+Doxorubicin vs Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma
Clinical trial NCT04650984 · UNKNOWN
Trial details
- NCT number
- NCT04650984
- Sponsor
- Philogen S.p.A.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-29
- Primary completion
- 2025-12-31
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.